
CORD-19:16a812de72963ceda960a168236e8dbe91832d45 / 44363-44565
Annnotations
CORD-19_Custom_license_subset
{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T221","span":{"begin":0,"end":202},"obj":"Sentence"}],"text":"Remyelination as Neuroprotection Using oligodendrocyte binding as a screening assay, we identified candidate human monoclonal antibodies that might also promote remyelination (Warrington et al., 2000) ."}
CORD-19-Sentences
{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T221","span":{"begin":0,"end":202},"obj":"Sentence"},{"id":"TextSentencer_T221","span":{"begin":0,"end":202},"obj":"Sentence"},{"id":"T75884","span":{"begin":0,"end":202},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Remyelination as Neuroprotection Using oligodendrocyte binding as a screening assay, we identified candidate human monoclonal antibodies that might also promote remyelination (Warrington et al., 2000) ."}
Epistemic_Statements
{"project":"Epistemic_Statements","denotations":[{"id":"T101","span":{"begin":0,"end":202},"obj":"Epistemic_statement"}],"text":"Remyelination as Neuroprotection Using oligodendrocyte binding as a screening assay, we identified candidate human monoclonal antibodies that might also promote remyelination (Warrington et al., 2000) ."}